Forsidebilde av showet Let’s Talk Medtech

Let’s Talk Medtech

Podkast av Informa Markets

engelsk

Teknologi og vitenskap

Prøv gratis i 14 dager

99 kr / Måned etter prøveperioden.Avslutt når som helst.

  • 20 timer lydbøker i måneden
  • Eksklusive podkaster
  • Gratis podkaster
Prøv gratis

Les mer Let’s Talk Medtech

MD+DI editors discuss current trends in the medical device and diagnostics industry, and point out developments to watch in the coming months.

Alle episoder

94 Episoder
episode Shattering the Product Adoption Lie in the Medical Device Industry artwork

Shattering the Product Adoption Lie in the Medical Device Industry

Holley Miller [https://www.linkedin.com/in/holleymalia/], founder and President of Grey Matter Marketing, is our guest on this episode of Let's Talk Medtech to discuss why it's so crucial to have the right message for your product.

3. mars 2026 - 26 min
episode Let's Talk Women's Health in 2026 artwork

Let's Talk Women's Health in 2026

Join Marissa Fayer [https://www.linkedin.com/in/marissa-fayer/], CEO of HerHealthEQ [https://www.herhealtheq.org/] and DeepLook Medical, [https://www.deeplookmedical.com/] as she explores the future of women's health and what it could look like in 2026 in this insightful episode of Let's Talk Medtech.

17. feb. 2026 - 24 min
episode Augurex Redefines Autoimmune Disease Detection artwork

Augurex Redefines Autoimmune Disease Detection

Augurex [https://augurex.com/] is a commercial-stage diagnostics company dedicated to the early identification and diagnosis of autoimmune disorders, enabling the optimization and personalization of treatment options for patients. Neil Klompas, the firm’s CEO, joins us for this episode of Let’s Talk Medtech to discuss how the company aims to accelerate the diagnosis of the disease and enhance autoimmune diagnostics for patients.

5. jan. 2026 - 27 min
episode How Stereotaxis Is Making Its Mark in Surgical Robotics: A Journey from Survival to Success artwork

How Stereotaxis Is Making Its Mark in Surgical Robotics: A Journey from Survival to Success

Surgical robotics is changing the landscape in healthcare. Stereotaxis [https://www.stereotaxis.com/] is hoping to carve out its niche in the massive space, which is home to Intuitive Surgical, Johnson & Johnson, and Medtronic. David Fischel, the St. Louis, MO-based company’s chairman and CEO, is featured in this episode of Let’s Talk Medtech to discuss Stereotaxis’ journey from surviving to thriving. The firm recently secured $50 million in funding and has had strong collaborations with NVIDIA. Fischel talks about the company’s game plan and his thoughts on the future of surgical robotics.

1. des. 2025 - 30 min
episode Audacity Drives Innovation in Medtech artwork

Audacity Drives Innovation in Medtech

Audacity is defined as the willingness to take bold risks. It’s also a mantra for Lishan Aklog, MD, a co-founder and CEO PavMed [https://www.pavmed.com/], the parent company of Lucid Diagnostics [https://www.luciddx.com/]. Aklog makes his second appearance on Let’s Talk Medtech [https://www.mddionline.com/series/let-s-talk-medtech] to give updates on both companies and to discuss his philosophy on why audacity breeds innovation.

3. nov. 2025 - 29 min
Enkelt å finne frem nye favoritter og lett å navigere seg gjennom innholdet i appen
Enkelt å finne frem nye favoritter og lett å navigere seg gjennom innholdet i appen
Liker at det er både Podcaster (godt utvalg) og lydbøker i samme app, pluss at man kan holde Podcaster og lydbøker atskilt i biblioteket.
Bra app. Oversiktlig og ryddig. MYE bra innhold⭐️⭐️⭐️

Velg abonnementet ditt

Mest populær

Premium

20 timer lydbøker

  • Eksklusive podkaster

  • Ingen annonser i Podimo shows

  • Avslutt når som helst

Prøv gratis i 14 dager
Deretter 99 kr / måned

Prøv gratis

Premium Plus

100 timer lydbøker

  • Eksklusive podkaster

  • Ingen annonser i Podimo shows

  • Avslutt når som helst

Prøv gratis i 14 dager
Deretter 169 kr / måned

Prøv gratis

Bare på Podimo

Populære lydbøker

Prøv gratis

Prøv gratis i 14 dager. 99 kr / Måned etter prøveperioden. Avslutt når som helst.